R3 Stem Cell today announced its recognition on CIO Bulletin's “Best Regenerative Medicine & Stem Cell Training ...

Off-label indications, use of compounded products could increase liability exposure ...

Mario Germano Giuliani and Lisa Giuliani have made an extraordinary gift of $27.8 million to support research in multiple myeloma, Dana-Farber Cancer Institute announced today. It is one of the ...

Sciton Inc., a pioneer and leader in medical and aesthetic laser and light-based technologies, today announced the launch of Super MOXI® with High Density (HD) Delivery™, a major evolution of its ...

Tailored antibiotic therapy for infective endocarditis was associated with a significant reduction in treatment duration, according to an open-label multicenter trial.

Milestone marks transition to active site-level execution with patient screening and enrollment expected to begin ...

News of Photonova Spectra’s latest regulatory achievement quickly follows its 510 (k) clearance by the U.S. Food and Drug ...

At-home subcutaneous lecanemab may ease the burden of frequent infusions, but clinicians still face key questions about ...

Beyond the potential clinical application, the study sheds new light on T cell biology and how cells are directed towards specific lineages.

Starting evolocumab in the cath lab before PCI did not, however, result in better clinical outcomes in the first year.

Super MOXI expands what's possible with MOXI. Harnessing the power of twin beams for treatments up to twice as fast and a more powerful 16W diode to efficiently treat larger areas, Super MOXI with HD ...

Johns Hopkins is recruiting healthy volunteers (18-60 years old) without any known lung disease for an imaging study that requires 5 visits over 1 month to our research center ...